Early tumor-informed circulating tumor DNA (ctDNA) dynamics correlate with response to first-line advanced NSCLC treated with pembrolizumab ± chemotherapy

The Journal of Liquid Biopsy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles